Countless patients have come forward with claims against the manufacturers of the sodium-glucose cotransporter 2 (SGLT2) inhibitor Invokana. After experiencing unannounced reactions to the medication, users of the drug are seeking out compensation.
A new class of medications called SGLT2 inhibitors are used for treatment for those with Type 2 diabetes. Unlike most medication for Type 2 diabetes, SGLT2s do not work to increase insulin levels. Instead, Invokana, and other drugs in this new class, prevent sugar from being reabsorbed into the blood, in the kidneys. This works by inhibiting a special protein in the kidney, responsible for...Read More
Patients who have filed lawsuits against manufacturers Johnson & Johnson state warning of the increased risk of kidney failure, heart attacks, and ketoacidosis were not disclosed. Agencies have reported adverse effects of this drug were higher than 92% of other medications within the monitored health group.
Within the first year of being released, there have been over 450...Read More
The family of Ida Mae Jones Jackson filed a wrongful death claim against Janssen in Louisiana, after she had experienced complications with the medication. After suffering from ketoacidosis which...Read More